查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828237

2025年全球组织微阵列市场报告

Tissue Microarray Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，组织微阵列市场规模强劲成长，从2024年的120.5亿美元成长至2025年的131.1亿美元，复合年增长率为8.8%。预测期内的成长可归因于精准医疗、药物研发、高效分析、慢性病盛行率上升以及生物样本库计画的兴起。

预计未来几年组织微阵列市场规模将快速成长，到2029年将达到208.5亿美元，复合年增长率为12.3%。预测期内的增长可归因于数位病理学的兴起、应用的不断扩展、生物製药行业的增长、监管支持和标准化以及人工智慧和机器学习的融合。预测期内的主要趋势包括成像技术的进步、3D组织微阵列的发展、高内涵筛检、标准化工作以及单细胞分析的整合。

组织晶片是一项强大的技术，通常使用石蜡块或福马林，可在单次实验中全面分析多种组织和细胞类型的抗原表现。它可以同时评估多个组织样本的蛋白质表现。

组织微阵列的主要类型包括免疫组织化学、萤光原位杂合反应(FISH)、冰冻组织阵列等。免疫组织化学 (IHC) 是一种用于诊断某些癌症（例如间皮瘤）的技术，它使用视觉标记来检测切片检查组织中的抗原。 DNA 微阵列、聚合酵素链锁反应(PCR)、新一代定序、北方印迹法和西方印渍术法等各种技术被用于肿瘤学、基因表现分析、单核苷酸多态性 (SNP) 检测、双链B-DNA 微阵列、比较杂合反应和定序生物资讯学等应用。这些技术应用于各种最终用户，包括製药和生物技术公司、研究机构和医院。

2025年春季美国关税大幅上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制价格上涨，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

组织微阵列研究报告是商业研究公司最新报告系列的一部分，该系列提供组织微阵列市场统计数据，包括全球市场规模、区域份额、竞争对手的组织微阵列市场份额、详细的组织微阵列市场细分、市场趋势以及组织微阵列行业的商机。本组织微阵列市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的全方位观点。

未来五年的预测成长率为12.3%，较我们先前对该市场的预测略有下降0.1%。下降的主要原因是美国与其他国家之间的关税影响。这种影响可能会直接影响美国，导致来自芬兰和加拿大等主要地区的精密石蜡块和微阵列列印组件的供应链中断，这可能会增加高性能病理学研究的成本。此外，这种影响可能会透过互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，在更广泛的范围内显现。

癌症发生率的上升预计将在未来推动组织微阵列市场的成长。癌症涵盖多种可能发生在任何器官或组织的疾病，由异常细胞不受控制地增殖、突破正常边界并可能扩散到其他器官或侵入邻近组织引起。组织微阵列在肿瘤学中用于分析不同肿瘤样本中癌症相关生物标记的表达。例如，根据英国癌症慈善机构麦克米伦癌症援助组织 (Macmillan Cancer Support) 2022 年 6 月发布的数据，预计英国癌症患者数量将在 2022 年达到 300 万，到 2025 年将增至近 350 万，到 2030 年将增至 400 万。因此，癌症患者数量的增加正在推动组织微阵列市场的成长。

个人化医疗需求的不断成长进一步推动了组织微阵列市场的成长。个人化医疗旨在根据个别特征客製化治疗方案，从而实现更有效的医疗保健。组织微阵列有助于同时分析多个组织样本，从而促进生物标记的快速评估。 2022年，美国食品药物管理局(FDA) 药品评估与研究中心 (CDER)核准了37个新分子实体 (NME)，其中约34%被归类为个人化医疗。这凸显了组织微阵列在推动个人化医疗方面的关键作用。

组织微阵列市场的一个显着趋势是策略伙伴关係关係的兴起。市场主要企业正在联手开发创新的组织微阵列技术。例如，Cureline集团与Cellecta公司合作推出了Tissue 2 Target Services，整合了两家公司在分子分析和生物样本管理方面的能力。此外，Ultivue公司和ngTMA正在合作推进多重萤光萤光分析，并将新型组织微阵列技术应用于科学研究中的空间分析。

组织微阵列市场中的公司正专注于先进的解决方案，例如微阵列平台，以提高高效能组织分析的准确性和效率。 MARGenomics 推出了 Applied Biosystems GeneChip 3000 Dx v2，这是一款先进的微阵列平台，也是首个在美国和欧洲获得监管部门批准用于诊断用途的平台。该平台由卡洛斯三世健康实验室和欧盟的 NextGenerationEU倡议资助，记录了基因组和表达微阵列的多种功能。

2022年11月，专注于临床前和临床研究服务的美国公司CureLine Group宣布与Cellecta Inc.合作推出Tissue 2 Target，旨在增强临床前和转化研究工作流程。此次合作将为专注于基因标靶和生物标记发现的研究人员打造全面的资源，简化高品质人类生物样本的分子表征流程。透过利用CureLine Group在生物样本管理方面的专业知识和Cellecta的功能基因组学技术，此次合作旨在促进循证决策，并最终改善转化研究和临床前计画的成果。同样总部位于美国的Cellecta则专注于功能基因体学，并为利用RNA干扰和CRISPR进行研究提供创新工具。

组织微阵列市场包括模具、针头和组织穿孔器的销售。该市场的价值指的是“出厂价”，即产品製造商或创造者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球组织微阵列：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球组织微阵列市场：成长率分析
  • 全球组织微阵列市场表现：规模与成长，2019-2024
  • 全球组织微阵列市场预测：规模与成长，2024-2029年，2034年
  • 全球组织微阵列：总潜在市场（TAM）

第六章 市场细分

  • 全球组织微阵列市场类型、效能及预测（2019-2024、2024-2029、2034）
  • 免疫组织化学
  • 萤光原位杂合反应（FISH）
  • 冷冻组织阵列
  • 其他的
  • 全球组织微阵列市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 去氧核糖核酸（DNA）微阵列
  • 聚合酵素链锁反应（PCR）
  • 下一代定序
  • 北方印迹法
  • 西方印渍术
  • 全球组织微阵列市场的应用、效能与预测（2019-2024、2024-2029、2034）
  • 肿瘤学
  • 基因表现
  • 单核苷酸多态性（SNP）检测
  • 双链B-DNA微阵列
  • 比较基因组杂合反应
  • 序列生物资讯学
  • 全球组织微阵列市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 製药和生物技术公司
  • 研究所
  • 医院
  • 全球组织微阵列市场：免疫组织化学细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 自动化免疫组织化学
  • 手动免疫组织化学
  • 多重免疫组织化学
  • 全球组织微阵列市场：萤光原位杂合反应(FISH) 细分市场、类型、性能及预测（2019-2024 年、2024-2029 年、2034 年）
  • 单色鱼
  • 多彩的鱼
  • DNAFISH
  • 全球组织微阵列市场：冷冻组织阵列细分市场、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 冷冻样本的组织微阵列
  • 速冻组织阵列
  • 全球组织微阵列市场：其他细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 核酸微阵列
  • RNA原位杂合反应
  • 石蜡包埋组织阵列

第七章 区域和国家分析

  • 全球组织微阵列市场：2019-2024 年、2024-2029 年与 2034 年区域表现与预测
  • 全球组织微阵列市场：国家、绩效与预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 组织微阵列市场：竞争格局
  • 组织微阵列市场：公司简介
    • Roche Group
    • Merck & Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson Biosciences
    • Agilent Technologies Inc.

第31章：其他领先和创新企业

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • PerkinElmer Inc.
  • Bio-Techne Corporation
  • Tristar Group
  • Evotec SE
  • Precision For Medicine Inc.
  • Molecular Devices LLC
  • BioIVT LLC
  • BioChain Institute Inc.
  • Creative Bioarray Co
  • 3DHISTECH Ltd.
  • Novus Biologicals LLC
  • PREMIER Biosoft International Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年组织微阵列市场：提供新机会的国家
  • 2029年组织微阵列市场：细分市场带来新机会
  • 2029年组织微阵列市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25354u

A tissue microarray is a high-throughput technology that enables comprehensive analysis of antigen expression across numerous tissues and cells in a single experiment, typically using paraffin blocks or formalin. It allows for the simultaneous assessment of protein expression in multiple tissue samples.

The primary types of tissue microarrays include immunohistochemistry, fluorescent in situ hybridization, frozen tissue array, and other variants. Immunohistochemistry (IHC) is a technique used to diagnose certain types of cancer, such as mesothelioma, by employing a visual marker to locate antigens in biopsy tissue. Various technologies such as DNA microarrays, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, western blotting, and others are utilized for applications in oncology, gene expression profiling, single nucleotide polymorphism (SNP) detection, double-stranded B-DNA microarrays, comparative genomic hybridization, sequencing bioinformatics, and more. These technologies find applications across different end-users, including pharmaceutical and biotechnological companies, research organizations, and hospitals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tissue microarray research report is one of a series of new reports from The Business Research Company that provides tissue microarray market statistics, including the tissue microarray industry's global market size, regional shares, competitors with tissue microarray market share, detailed tissue microarray market segments, market trends and opportunities, and any further data you may need to thrive in the tissue microarray industry. This tissue microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue microarray market size has grown strongly in recent years. It will grow from $12.05 billion in 2024 to $13.11 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rise of precision medicine, drug discovery and development, efficient analysis, rising prevalence of chronic diseases, biobanking initiatives.

The tissue microarray market size is expected to see rapid growth in the next few years. It will grow to $20.85 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to emergence of digital pathology, expanded applications, growing biopharmaceutical industry, regulatory support and standards, ai and machine learning integration. Major trends in the forecast period include advancements in imaging technologies, development of 3d tissue microarrays, high-content screening, standardization initiatives, and single-cell analysis integration.

The forecast of 12.3% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for precision paraffin blocks and microarray printing components, sourced from key regions such as Finland and Canada, could lead to increased costs for high-throughput pathology research.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of cancer is expected to drive the growth of the tissue microarray market in the future. Cancer encompasses a range of diseases that can arise in any organ or tissue when abnormal cells multiply uncontrollably, breach their normal boundaries, and potentially spread to other organs or invade nearby tissues. Tissue microarrays are utilized in oncology to analyze the expression of cancer-related biomarkers in different tumor samples. For example, in June 2022, data published by Macmillan Cancer Support, a UK-based cancer charity, indicated that the number of individuals living with cancer reached 3 million in 2022, with projections suggesting it will rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Therefore, the increasing number of cancer cases is driving the growth of the tissue microarray market.

The growth of the tissue microarray market is further fueled by the rising demand for personalized medicine. Personalized medicine tailors medical treatment to individual characteristics for more effective healthcare. Tissue microarrays are instrumental in analyzing multiple tissue samples concurrently, facilitating rapid assessment of biomarkers. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines. This emphasizes the integral role of tissue microarrays in advancing personalized medicine.

A notable trend in the tissue microarray market is the emergence of strategic partnerships. Major companies in the market are forming alliances to develop innovative tissue microarray technologies. For instance, The Cureline Group partnered with Cellecta Inc. to launch Tissue 2 Target Services, combining their competencies in molecular analysis and biospecimen management. Another collaboration involves Ultivue Inc. and ngTMA, aiming to advance multiplexed immunofluorescence assays and apply new tissue microarray technologies for spatial analysis in scientific research.

Companies in the tissue microarray market are focusing on advanced solutions, such as microarray platforms, to enhance precision and efficiency in high-throughput tissue analysis. MARGenomics launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform, the first in Europe and the United States to receive regulatory approval for diagnostic purposes. This platform, funded by the Carlos III Health Institute and the European Union's NextGenerationEU initiative, offers diverse functionalities for genomic and expression microarrays.

In November 2022, The Cureline Group, a US-based company specializing in preclinical and clinical research services, announced a partnership with Cellecta Inc. to launch Tissue 2 Target, which aims to enhance preclinical and translational research workflows. This collaboration will create a comprehensive resource for researchers focused on gene target and biomarker discovery, streamlining the molecular characterization of high-quality human biospecimens. By leveraging The Cureline Group's expertise in biospecimen management alongside Cellecta's functional genomics techniques, the partnership seeks to facilitate evidence-based decision-making, ultimately improving the outcomes of translational and preclinical programs. Cellecta, Inc., also based in the US, specializes in functional genomics and offers innovative tools for RNA interference and CRISPR-based research.

Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tissue microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue microarray market consists of sales of molds, needles, and tissue punches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Microarray Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue microarray ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue microarray market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Immunohistochemistry; Fluorescent In Situ Hybridization; Frozen Tissue Array; Other Types
  • 2) By Technology: Deoxyribonucleic Acid (DNA) Microarray; Polymerase Chain Reaction (PCR); Next-Generation Sequencing; Northern Blotting; Western Blotting
  • 3) By Application: Oncology; Gene Expression Profiling; Single Nucleotide Polymorphism (SNP) Detection; Double-Stranded B-DNA Microarrays; Comparative Genomic Hybridization; Sequencing Bioinformatics
  • 4) By End-User: Pharmaceutical And Biotechnological Companies; Research Organization; Hospitals
  • Subsegments:
  • 1) By Immunohistochemistry: Automated Immunohistochemistry; Manual Immunohistochemistry; Multiplex Immunohistochemistry
  • 2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH; Multi-Color FISH; DNA FISH
  • 3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples; Snap-Frozen Tissue Array
  • 4) By Other Types: Nucleic Acid Microarrays; RNA In Situ Hybridization; Paraffin-Embedded Tissue Array
  • Companies Mentioned: Roche Group; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Becton, Dickinson Biosciences; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; Qiagen NV; PerkinElmer Inc.; Bio-Techne Corporation; Tristar Group; Evotec SE; Precision For Medicine Inc.; Molecular Devices LLC; BioIVT LLC; BioChain Institute Inc.; Creative Bioarray Co; 3DHISTECH Ltd.; Novus Biologicals LLC; PREMIER Biosoft International Inc.; iSpecimen Inc.; OriGene Technologies Inc.; Bio SB Inc.; ProteoGenex Inc.; Z Biotech LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Microarray Market Characteristics

3. Tissue Microarray Market Trends And Strategies

4. Tissue Microarray Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tissue Microarray Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tissue Microarray PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tissue Microarray Market Growth Rate Analysis
  • 5.4. Global Tissue Microarray Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tissue Microarray Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tissue Microarray Total Addressable Market (TAM)

6. Tissue Microarray Market Segmentation

  • 6.1. Global Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunohistochemistry
  • Fluorescent In Situ Hybridization
  • Frozen Tissue Array
  • Other Types
  • 6.2. Global Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid (DNA) Microarray
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing
  • Northern Blotting
  • Western Blotting
  • 6.3. Global Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Gene Expression Profilinng
  • Single Nucleotide Polymorphism (SNP) Detection
  • Double-Stranded B-DNA Microarrays
  • Comparative Genomic Hybridization
  • Sequencing Bioinformatics
  • 6.4. Global Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnological Companies
  • Research Organization
  • Hospitals
  • 6.5. Global Tissue Microarray Market, Sub-Segmentation Of Immunohistochemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Immunohistochemistry
  • Manual Immunohistochemistry
  • Multiplex Immunohistochemistry
  • 6.6. Global Tissue Microarray Market, Sub-Segmentation Of Fluorescent In Situ Hybridization (FISH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Color FISH
  • Multi-Color FISH
  • DNA FISH
  • 6.7. Global Tissue Microarray Market, Sub-Segmentation Of Frozen Tissue Array,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Microarray from Frozen Samples
  • Snap-Frozen Tissue Array
  • 6.8. Global Tissue Microarray Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nucleic Acid Microarrays
  • RNA In Situ Hybridization
  • Paraffin-Embedded Tissue Array

7. Tissue Microarray Market Regional And Country Analysis

  • 7.1. Global Tissue Microarray Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tissue Microarray Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Microarray Market

  • 8.1. Asia-Pacific Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Microarray Market

  • 9.1. China Tissue Microarray Market Overview
  • 9.2. China Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Microarray Market

  • 10.1. India Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Microarray Market

  • 11.1. Japan Tissue Microarray Market Overview
  • 11.2. Japan Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Microarray Market

  • 12.1. Australia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Microarray Market

  • 13.1. Indonesia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Microarray Market

  • 14.1. South Korea Tissue Microarray Market Overview
  • 14.2. South Korea Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Microarray Market

  • 15.1. Western Europe Tissue Microarray Market Overview
  • 15.2. Western Europe Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Microarray Market

  • 16.1. UK Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Microarray Market

  • 17.1. Germany Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Microarray Market

  • 18.1. France Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Microarray Market

  • 19.1. Italy Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Microarray Market

  • 20.1. Spain Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Microarray Market

  • 21.1. Eastern Europe Tissue Microarray Market Overview
  • 21.2. Eastern Europe Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Microarray Market

  • 22.1. Russia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Microarray Market

  • 23.1. North America Tissue Microarray Market Overview
  • 23.2. North America Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Microarray Market

  • 24.1. USA Tissue Microarray Market Overview
  • 24.2. USA Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Microarray Market

  • 25.1. Canada Tissue Microarray Market Overview
  • 25.2. Canada Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Microarray Market

  • 26.1. South America Tissue Microarray Market Overview
  • 26.2. South America Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Microarray Market

  • 27.1. Brazil Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Microarray Market

  • 28.1. Middle East Tissue Microarray Market Overview
  • 28.2. Middle East Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Microarray Market

  • 29.1. Africa Tissue Microarray Market Overview
  • 29.2. Africa Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Microarray Market Competitive Landscape And Company Profiles

  • 30.1. Tissue Microarray Market Competitive Landscape
  • 30.2. Tissue Microarray Market Company Profiles
    • 30.2.1. Roche Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickinson Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Microarray Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Qiagen NV
  • 31.4. PerkinElmer Inc.
  • 31.5. Bio-Techne Corporation
  • 31.6. Tristar Group
  • 31.7. Evotec SE
  • 31.8. Precision For Medicine Inc.
  • 31.9. Molecular Devices LLC
  • 31.10. BioIVT LLC
  • 31.11. BioChain Institute Inc.
  • 31.12. Creative Bioarray Co
  • 31.13. 3DHISTECH Ltd.
  • 31.14. Novus Biologicals LLC
  • 31.15. PREMIER Biosoft International Inc.

32. Global Tissue Microarray Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Microarray Market

34. Recent Developments In The Tissue Microarray Market

35. Tissue Microarray Market High Potential Countries, Segments and Strategies

  • 35.1 Tissue Microarray Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tissue Microarray Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tissue Microarray Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer